49.60
Travere Therapeutics Inc (TVTX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
33.32%
169.58
|
127.20 | 129.69 | 164.86 | 114.45 |
| Cost Of Revenue |
11.49%
2.174
|
1.95 | 2.553 | 1.585 | 1.521 |
| Selling, General, and Administrative |
19.76%
96.11
|
80.25 | - | - | - |
| Costs And Expenses |
0.92%
165.63
|
164.11 | 162.12 | 139.93 | 127.10 |
| Operating Income/Loss |
110.71%
3.954
|
-36.91 | -32.43 | 24.93 | -12.65 |
| Nonoperating Income/Loss |
20,284%
-38.95
|
0.193 | 11.36 | 0.783 | -0.085 |
| Income/Loss From Continuing Operations Before Tax |
4.69%
-35.00
|
-36.72 | -21.07 | 25.71 | -12.73 |
| Income Tax Expense/Benefit |
70.00%
-0.204
|
-0.12 | 0.921 | 0.008 | 0.02 |
| Income/Loss From Continuing Operations After Tax |
4.93%
-34.80
|
-36.60 | -21.99 | 25.71 | -12.76 |
| Income/Loss From Discontinued Operations, Net Of Tax |
100.00%
-
|
-0.50 | 24.71 | - | - |
|
|
6.21%
-34.80
|
-37.10 | 2.729 | 25.71 | -12.76 |
| Basic Average Shares |
1.75%
93.48
|
91.87 | 0.3646 | 89.23 | 88.95 |
| Diluted Average Shares |
1.75%
93.48
|
91.87 | 0.3646 | 102.62 | 88.95 |
| Basic Earnings Per Share |
7.50%
-0.37
|
-0.40 | 0.03 | 0.29 | -0.14 |
| Diluted Earnings Per Share |
7.50%
-0.37
|
-0.40 | 0.03 | 0.28 | -0.14 |
大文字化:
|
ボリューム (24 時間):